Skip to main content

Chlamydia pneumoniae

The Lung and the Heart

  • Book
  • © 1999

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (25 chapters)

  1. History of Chlamydia pneumoniae (TWAR)

  2. Chlamydia pneumoniae: Culture Methods

  3. Serology for Chlamydia pneumoniae (TWAR)

  4. Chlamydia pneumoniae: Molecular Biology Methods

  5. Chlamydia pneumoniae Infections: Applications of Laboratory Methods

  6. Chlamydia pneumoniae: How to Document Respiratory Infection

  7. Chlamydia pneumoniae: Epidemiology

  8. Pharmacological and Pharmacokinetic Basis of Chlamydia pneumoniae Treatment

  9. Chlamydia pneumoniae: Clinical Characteristics of Acute Respiratory Infections

  10. Are Atypical Pathogens Important for Patients with Community-Acquired Pneumonia?

  11. Immunology of Chlamydia pneumoniae

  12. Chronic Chlamydia pneumoniae Infections

  13. Chlamydia pneumoniae:A New Possible Cause of Asthma

  14. Chlamydia pneumoniae: An Important Pathogen in Chronic Bronchitis

  15. Chlamydia pneumoniae: A New Threat for HIV-infected Subjects

  16. Chlamydia pneumoniae: Epidemiology of a New Cardiovascular Risk Factor

  17. Chlamydia pneumoniae and Atherosclerosis: Mechanisms of Vascular Damage

  18. Chlamydia pneumoniae and Atherosclerosis: Animal Models

  19. Open and Controlled Intervention Trials for “Unusual” Anti-Chlamydia pneumoniae Indications: Asthma, Atherosclerosis, Myocardial Infarction

Keywords

About this book

Chlamydia pneumoniae is now recognized as an important human pathogen. Chlamydia pneumoniae is involved in 5%-15% of community acquired pneumonias, and recent data indicate its relevance in severe pneumonia and as a respiratory pathogen in immunocompromised subjects. A causal role for Chlamydia pneumoniae in the initiation, exacerbations and promotion of asthma has been suggested. Approximately 5% of chronic bronchitis exacerbations have been attributed to Chlamydia pneumoniae infections, and chronic infection may facilitate access of other pathogens to the lower respiratory tract. Another field of potential great social impact is the possible involvement of Chlamydia pneumoniae in the pathogenesis of atherosclerosis and related cardiovascular diseases. This book presents the current state-of-the-art knowledge on Chlamydia pneumoniae infection and highlights future lines of research.

Editors and Affiliations

  • Institute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore, Milan, Italy

    Luigi Allegra, Francesco Blasi

Bibliographic Information

  • Book Title: Chlamydia pneumoniae

  • Book Subtitle: The Lung and the Heart

  • Editors: Luigi Allegra, Francesco Blasi

  • DOI: https://doi.org/10.1007/978-88-470-2280-5

  • Publisher: Springer Milano

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Italia 1999

  • Softcover ISBN: 978-88-470-0047-6Published: 01 January 1999

  • eBook ISBN: 978-88-470-2280-5Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: VIII, 205

  • Topics: Pneumology/Respiratory System

Publish with us